ArticleAmerican journal of translational research2025
Relationship between serum uric acid and ventricular diastolic dysfunction in type 2 diabetes mellitus patients.
Article in American journal of translational research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo investigate the correlation of serum uric acid (SUA) levels with ventricular diastolic dysfunction (DD) in the diabetic population.
methodsClinical data from 702 patients with type 2 diabetes mellitus (T2DM), including 394 males and 308 females, were retrospectively analyzed in this study. The data included demographic characteristics, biochemical test results, and echocardiography findings. Univariate and multivariate logistic regression analyses were performed to assess the association between SUA and DD. Additionally, the diagnostic efficacies of SUA and the multivariate logistic regression model (Logit P) for DD were evaluated using receiver operating characteristic (ROC) curves.
resultsCompared to T2DM patients with normal diastolic function, those with DD had a higher prevalence of hypertension, older age, longer diabetes duration, elevated levels of low-density lipoprotein cholesterol (LDL-c), total cholesterol (TC), blood urea nitrogen (BUN), SUA, and hemoglobin A1c (HbA1c), as well as lower levels of 1,5-anhydroglucitol (1,5-AG) and estimated glomerular filtration rate (eGFR) (P<0.05). As indicated by the Logistic regression analysis, gender, age, and SUA were independent risk factors for DD (P<0.05). Women had a 47.8% lower risk of DD compared to men [95% CI (0.318-0.718)]. The risk of DD increased by 6.8% for each one-year rise in age [OR 1.068, 95% CI (1.051-1.085)] and by 0.5% for each 1 mmol/L increase in SUA [OR 1.005, 95% CI (1.003-1.007)]. The regression model incorporating sex, age, and SUA exhibited an area under the curve (AUC) of 0.753 (95% CI 0.712-0.794) for diagnosing DD, with a sensitivity of 65.65% and specificity of 78.65%.
conclusionsGender, age, and SUA were independent factors influencing the development of DD in T2DM patients. Among them, SUA is the only modifiable factor. Early and long-term control of SUA levels is essential to reduce the risk of DD in T2DM patients.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.